{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:26:26Z","timestamp":1793701586167,"version":"4.5.1"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:00:00Z","timestamp":1614816000000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deutsche Forschungsgemeinschaft","award":["325768017"],"award-info":[{"award-number":["325768017"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["325768017"],"award-info":[{"award-number":["325768017"]}]},{"name":"Deutsche Forschungsgemeinschaft","award":["325768017"],"award-info":[{"award-number":["325768017"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2021,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adrenal insufficiency (AI) is a life-threatening condition requiring life-long glucocorticoid (GC) substitution therapy, as well as stress adaptation to prevent adrenal crises. The number of individuals with primary and secondary adrenal insufficiency in Europe is estimated to be 20\u201350\/100.000. A growing number of AI cases are due to side effects of GC treatment used in different treatment strategies for cancer and to immunotherapy in cancer treatment. The benefit of hormone replacement therapy is evident but long-term adverse effects may arise due to the non-physiological GC doses and treatment regimens used. Given multiple GC replacement formulations available comprising short-acting, intermediate, long-acting and novel modified-release hydrocortisone as well as subcutaneous formulations, this review offers a concise summary on the latest therapeutic improvements for treatment of AI and prevention of adrenal crises. As availability of various glucocorticoid formulations and access to expert centers across Europe varies widely, European Reference Networks on rare endocrine conditions aim at harmonizing treatment and ensure access to specialized patient care for individual case-by-case treatment decisions. To improve the availability across Europe to cost effective oral and parenteral formulations of hydrocortisone will save lives.<\/jats:p>","DOI":"10.1007\/s12020-021-02649-6","type":"journal-article","created":{"date-parts":[[2021,3,4]],"date-time":"2021-03-04T00:02:57Z","timestamp":1614816177000},"page":"586-594","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis"],"prefix":"10.1007","volume":"71","author":[{"name":"On Behalf of Endo ERN (MTG1)","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Nowotny","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. Faisal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Bensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan G.","family":"Beun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Br\u00f6samle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Chifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedi","family":"Claahsen van der Grinten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eystein","family":"Husebye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jette","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Loli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svetlana","family":"Lajic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,4]]},"reference":[{"issue":"9935","key":"2649_CR1","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1016\/S0140-6736(13)61684-0","volume":"383","author":"E Charmandari","year":"2014","unstructured":"E. Charmandari, N.C. Nicolaides, G.P. Chrousos, Adrenal insufficiency. Lancet 383(9935), 2152\u20132167 (2014). https:\/\/doi.org\/10.1016\/S0140-6736(13)61684-0","journal-title":"Lancet"},{"issue":"9372","key":"2649_CR2","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","volume":"361","author":"W Arlt","year":"2003","unstructured":"W. Arlt, B. Allolio, Adrenal insufficiency. Lancet 361(9372), 1881\u20131893 (2003). https:\/\/doi.org\/10.1016\/S0140-6736(03)13492-7","journal-title":"Lancet"},{"key":"2649_CR3","doi-asserted-by":"publisher","unstructured":"T. Li, J.L. Cunningham, W.P. Gilliam, L. Loukianova, D.M. Donegan, I. Bancos, Prevalence of opioid-induced adrenal insufficiency in patients taking chronic opioids. J. Clin. Endocrinol. Metab. 105(10) (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa499","DOI":"10.1210\/clinem\/dgaa499"},{"key":"2649_CR4","doi-asserted-by":"publisher","unstructured":"F. de Vries, M. Bruin, D.J. Lobatto, O.M. Dekkers, J.W. Schoones, W.R. van Furth, A.M. Pereira, N. Karavitaki, N.R. Biermasz, A.H. Zamanipoor Najafabadi, Opioids and their endocrine effects: a systematic review and meta-analysis. J. Clin. Endocrinol. Metab. 105(3) (2020). https:\/\/doi.org\/10.1210\/clinem\/dgz022","DOI":"10.1210\/clinem\/dgz022"},{"issue":"1","key":"2649_CR5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1210\/er.2015-1080","volume":"38","author":"H Oster","year":"2017","unstructured":"H. Oster, E. Challet, V. Ott, E. Arvat, E.R. de Kloet, D.J. Dijk, S. Lightman, A. Vgontzas, E. Van Cauter, The functional and clinical significance of the 24-hour rhythm of circulating glucocorticoids. Endocr. Rev. 38(1), 3\u201345 (2017). https:\/\/doi.org\/10.1210\/er.2015-1080","journal-title":"Endocr. Rev."},{"issue":"1","key":"2649_CR6","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-18-0102","volume":"179","author":"AC Moreira","year":"2018","unstructured":"A.C. Moreira, S.R. Antonini, M. de Castro, Mechanisms in endocrinology: a sense of time of the glucocorticoid circadian clock: from the ontogeny to the diagnosis of Cushing\u2019s syndrome. Eur. J. Endocrinol. 179(1), R1\u2013R18 (2018). https:\/\/doi.org\/10.1530\/EJE-18-0102","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"2649_CR7","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.tem.2009.12.011","volume":"21","author":"N Nader","year":"2010","unstructured":"N. Nader, G.P. Chrousos, T. Kino, Interactions of the circadian CLOCK system and the HPA axis. Trends Endocrinol. Metab. 21(5), 277\u2013286 (2010). https:\/\/doi.org\/10.1016\/j.tem.2009.12.011","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"2649_CR8","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/cen.12470","volume":"81","author":"GM Russell","year":"2014","unstructured":"G.M. Russell, C. Durant, A. Ataya, C. Papastathi, R. Bhake, W. Woltersdorf, S. Lightman, Subcutaneous pulsatile glucocorticoid replacement therapy. Clin. Endocrinol. (Oxf.) 81(2), 289\u2013293 (2014). https:\/\/doi.org\/10.1111\/cen.12470","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"2","key":"2649_CR9","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","volume":"101","author":"SR Bornstein","year":"2016","unstructured":"S.R. Bornstein, B. Allolio, W. Arlt, A. Barthel, A. Don-Wauchope, G.D. Hammer, E.S. Husebye, D.P. Merke, M.H. Murad, C.A. Stratakis, D.J. Torpy, Diagnosis and treatment of primary adrenal insufficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(2), 364\u2013389 (2016). https:\/\/doi.org\/10.1210\/jc.2015-1710","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"2649_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1210\/jcem-72-1-39","volume":"72","author":"NV Esteban","year":"1991","unstructured":"N.V. Esteban, T. Loughlin, A.L. Yergey, J.K. Zawadzki, J.D. Booth, J.C. Winterer, D.L. Loriaux, Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry. J. Clin. Endocrinol. Metab. 72(1), 39\u201345 (1991). https:\/\/doi.org\/10.1210\/jcem-72-1-39","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2649_CR11","doi-asserted-by":"publisher","first-page":"4043","DOI":"10.1210\/jc.2018-01865","volume":"103","author":"PW Speiser","year":"2018","unstructured":"P.W. Speiser, W. Arlt, R.J. Auchus, L.S. Baskin, G.S. Conway, D.P. Merke, H.F.L. Meyer-Bahlburg, W.L. Miller, M.H. Murad, S.E. Oberfield, P.C. White, Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 103(11), 4043\u20134088 (2018). https:\/\/doi.org\/10.1210\/jc.2018-01865","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2649_CR12","doi-asserted-by":"publisher","first-page":"5110","DOI":"10.1210\/jc.2010-0917","volume":"95","author":"W Arlt","year":"2010","unstructured":"W. Arlt, D.S. Willis, S.H. Wild, N. Krone, E.J. Doherty, S. Hahner, T.S. Han, P.V. Carroll, G.S. Conway, D.A. Rees, R.H. Stimson, B.R. Walker, J.M. Connell, R.J. Ross; United Kingdom Congenital Adrenal Hyperplasia Adult Study, E., Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients. J. Clin. Endocrinol. Metab. 95(11), 5110\u20135121 (2010). https:\/\/doi.org\/10.1210\/jc.2010-0917","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2649_CR13","doi-asserted-by":"publisher","first-page":"105540","DOI":"10.1016\/j.jsbmb.2019.105540","volume":"197","author":"L Paizoni","year":"2020","unstructured":"L. Paizoni, M.K. Auer, H. Schmidt, A. Hubner, M. Bidlingmaier, N. Reisch, Effect of androgen excess and glucocorticoid exposure on metabolic risk profiles in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Steroid Biochem Mol. Biol. 197, 105540 (2020). https:\/\/doi.org\/10.1016\/j.jsbmb.2019.105540","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"3","key":"2649_CR14","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1111\/cen.13267","volume":"86","author":"RD Murray","year":"2017","unstructured":"R.D. Murray, B. Ekman, S. Uddin, C. Marelli, M. Quinkler, P.M. Zelissen, E.U.A.I.R.I. the, Management of glucocorticoid replacement in adrenal insufficiency shows notable heterogeneity-data from the EU-AIR. Clin. Endocrinol. (Oxf.) 86(3), 340\u2013346 (2017). https:\/\/doi.org\/10.1111\/cen.13267","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"2649_CR15","doi-asserted-by":"publisher","first-page":"105734","DOI":"10.1016\/j.jsbmb.2020.105734","volume":"204","author":"MK Auer","year":"2020","unstructured":"M.K. Auer, L. Paizoni, L.C. Hofbauer, M. Rauner, Y. Chen, H. Schmidt, A. Huebner, M. Bidlingmaier, N. Reisch, Effects of androgen excess and glucocorticoid exposure on bone health in adult patients with 21-hydroxylase deficiency. J. Steroid Biochem Mol. Biol. 204, 105734 (2020). https:\/\/doi.org\/10.1016\/j.jsbmb.2020.105734","journal-title":"J. Steroid Biochem Mol. Biol."},{"issue":"6","key":"2649_CR16","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1530\/EC-18-0160","volume":"7","author":"KR Frey","year":"2018","unstructured":"K.R. Frey, T. Kienitz, J. Schulz, M. Ventz, K. Zopf, M. Quinkler, Prednisolone is associated with a worse bone mineral density in primary adrenal insufficiency. Endocr. Connect 7(6), 811\u2013818 (2018). https:\/\/doi.org\/10.1530\/EC-18-0160","journal-title":"Endocr. Connect"},{"issue":"1","key":"2649_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1530\/EC-16-0081","volume":"6","author":"M Quinkler","year":"2017","unstructured":"M. Quinkler, B. Ekman, C. Marelli, S. Uddin, P. Zelissen, R.D. Murray, E.-A. Investigators, Prednisolone is associated with a worse lipid profile than hydrocortisone in patients with adrenal insufficiency. Endocr. Connect 6(1), 1\u20138 (2017). https:\/\/doi.org\/10.1530\/EC-16-0081","journal-title":"Endocr. Connect"},{"issue":"6","key":"2649_CR18","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1210\/js.2019-00136","volume":"3","author":"E Whittle","year":"2019","unstructured":"E. Whittle, H. Falhammar, Glucocorticoid regimens in the treatment of congenital adrenal hyperplasia: a systematic review and meta-analysis. J. Endocr. Soc. 3(6), 1227\u20131245 (2019). https:\/\/doi.org\/10.1210\/js.2019-00136","journal-title":"J. Endocr. Soc."},{"issue":"5","key":"2649_CR19","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","volume":"69","author":"S Bensing","year":"2008","unstructured":"S. Bensing, L. Brandt, F. Tabaroj, O. Sjoberg, B. Nilsson, A. Ekbom, P. Blomqvist, O. Kampe, Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency. Clin. Endocrinol. (Oxf.) 69(5), 697\u2013704 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2008.03340.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"12","key":"2649_CR20","doi-asserted-by":"publisher","first-page":"E2715","DOI":"10.1210\/jc.2014-2957","volume":"99","author":"H Falhammar","year":"2014","unstructured":"H. Falhammar, L. Frisen, C. Norrby, A.L. Hirschberg, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 99(12), E2715\u20132721 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2957","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2649_CR21","doi-asserted-by":"publisher","first-page":"1466","DOI":"10.1210\/jc.2012-4059","volume":"98","author":"P Burman","year":"2013","unstructured":"P. Burman, A.F. Mattsson, G. Johannsson, C. Hoybye, H. Holmer, P. Dahlqvist, K. Berinder, B.E. Engstrom, B. Ekman, E.M. Erfurth, J. Svensson, J. Wahlberg, F.A. Karlsson, Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality. J. Clin. Endocrinol. Metab. 98(4), 1466\u20131475 (2013). https:\/\/doi.org\/10.1210\/jc.2012-4059","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"12","key":"2649_CR22","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","volume":"91","author":"R Bergthorsdottir","year":"2006","unstructured":"R. Bergthorsdottir, M. Leonsson-Zachrisson, A. Oden, G. Johannsson, Premature mortality in patients with Addison\u2019s disease: a population-based study. J. Clin. Endocrinol. Metab. 91(12), 4849\u20134853 (2006). https:\/\/doi.org\/10.1210\/jc.2006-0076","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2649_CR23","doi-asserted-by":"publisher","unstructured":"J. Martin-Grace, R. Dineen, M. Sherlock, C.J. Thompson, Adrenal insufficiency: physiology, clinical presentation and diagnostic challenges. Clin. Chim. Acta (2020). https:\/\/doi.org\/10.1016\/j.cca.2020.01.029","DOI":"10.1016\/j.cca.2020.01.029"},{"issue":"10","key":"2649_CR24","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1210\/jc.2007-0685","volume":"92","author":"S Hahner","year":"2007","unstructured":"S. Hahner, M. Loeffler, M. Fassnacht, D. Weismann, A.C. Koschker, M. Quinkler, O. Decker, W. Arlt, B. Allolio, Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J. Clin. Endocrinol. Metab. 92(10), 3912\u20133922 (2007). https:\/\/doi.org\/10.1210\/jc.2007-0685","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"2649_CR25","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1530\/EJE-12-0879","volume":"168","author":"LC Smans","year":"2013","unstructured":"L.C. Smans, P.C. Souverein, H.G. Leufkens, A.I. Hoepelman, P.M. Zelissen, Increased use of antimicrobial agents and hospital admission for infections in patients with primary adrenal insufficiency: a cohort study. Eur. J. Endocrinol. 168(4), 609\u2013614 (2013). https:\/\/doi.org\/10.1530\/EJE-12-0879","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"2649_CR26","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1530\/EJE-16-0969","volume":"176","author":"I Bancos","year":"2017","unstructured":"I. Bancos, J. Hazeldine, V. Chortis, P. Hampson, A.E. Taylor, J.M. Lord, W. Arlt, Primary adrenal insufficiency is associated with impaired natural killer cell function: a potential link to increased mortality. Eur. J. Endocrinol. 176(4), 471\u2013480 (2017). https:\/\/doi.org\/10.1530\/EJE-16-0969","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"2649_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/cen.12603","volume":"82","author":"G Johannsson","year":"2015","unstructured":"G. Johannsson, A. Falorni, S. Skrtic, H. Lennernas, M. Quinkler, J.P. Monson, P.M. Stewart, Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy. Clin. Endocrinol. (Oxf.) 82(1), 2\u201311 (2015). https:\/\/doi.org\/10.1111\/cen.12603","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"9","key":"2649_CR28","doi-asserted-by":"publisher","first-page":"3520","DOI":"10.1210\/JC.2015-2093","volume":"100","author":"H Falhammar","year":"2015","unstructured":"H. Falhammar, L. Frisen, A.L. Hirschberg, C. Norrby, C. Almqvist, A. Nordenskjold, A. Nordenstrom, Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: A Swedish Population-Based National Cohort Study. J. Clin. Endocrinol. Metab. 100(9), 3520\u20133528 (2015). https:\/\/doi.org\/10.1210\/JC.2015-2093","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2649_CR29","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1210\/jc.2016-2522","volume":"102","author":"F Dalin","year":"2017","unstructured":"F. Dalin, G. Nordling Eriksson, P. Dahlqvist, A. Hallgren, J. Wahlberg, O. Ekwall, S. Soderberg, J. Ronnelid, P. Olcen, O. Winqvist, S.B. Catrina, B. Kristrom, M. Laudius, M. Isaksson, M. Halldin Stenlid, J. Gustafsson, G. Gebre-Medhin, S. Bjornsdottir, A. Janson, A.K. Akerman, J. Aman, K. Duchen, R. Bergthorsdottir, G. Johannsson, E. Lindskog, M. Landin-Olsson, M. Elfving, E. Waldenstrom, A.L. Hulting, O. Kampe, S. Bensing, Clinical and immunological characteristics of autoimmune addison disease: a Nationwide Swedish Multicenter Study. J. Clin. Endocrinol. Metab. 102(2), 379\u2013389 (2017). https:\/\/doi.org\/10.1210\/jc.2016-2522","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"2649_CR30","doi-asserted-by":"publisher","first-page":"2031","DOI":"10.1210\/jc.2018-02298","volume":"104","author":"J Skov","year":"2019","unstructured":"J. Skov, A. Sundstrom, J.F. Ludvigsson, O. Kampe, S. Bensing, Sex-Specific risk of cardiovascular disease in autoimmune addison disease-a population-based cohort study. J. Clin. Endocrinol. Metab. 104(6), 2031\u20132040 (2019). https:\/\/doi.org\/10.1210\/jc.2018-02298","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2649_CR31","doi-asserted-by":"publisher","first-page":"R432","DOI":"10.1016\/j.cub.2016.04.011","volume":"26","author":"TMM R\u00f6nneberg","year":"2016","unstructured":"T.M.M. R\u00f6nneberg,, The circadian clock and human health. Curr. Biol. 26, R432\u2013443 (2016). https:\/\/doi.org\/10.1016\/j.cub.2016.04.011","journal-title":"Curr. Biol."},{"key":"2649_CR32","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.psyneuen.2016.06.015","volume":"72","author":"CD Andela","year":"2016","unstructured":"C.D. Andela, S.M. Staufenbiel, S.D. Joustra, A.M. Pereira, E.F. van Rossum, N.R. Biermasz, Quality of life in patients with adrenal insufficiency correlates stronger with hydrocortisone dosage, than with long-term systemic cortisol levels. Psychoneuroendocrinology 72, 80\u201386 (2016). https:\/\/doi.org\/10.1016\/j.psyneuen.2016.06.015","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"2649_CR33","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/EJE-09-0170","volume":"161","author":"G Johannsson","year":"2009","unstructured":"G. Johannsson, R. Bergthorsdottir, A.G. Nilsson, H. Lennernas, T. Hedner, S. Skrtic, Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a pharmacokinetic study. Eur. J. Endocrinol. 161(1), 119\u2013130 (2009). https:\/\/doi.org\/10.1530\/EJE-09-0170","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2649_CR34","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1136\/archdischild-2015-309538","volume":"102","author":"J Porter","year":"2017","unstructured":"J. Porter, J. Blair, R.J. Ross, Is physiological glucocorticoid replacement important in children? Arch. Dis. Child 102(2), 199\u2013205 (2017). https:\/\/doi.org\/10.1136\/archdischild-2015-309538","journal-title":"Arch. Dis. Child"},{"issue":"2","key":"2649_CR35","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1210\/jc.2011-1926","volume":"97","author":"G Johannsson","year":"2012","unstructured":"G. Johannsson, A.G. Nilsson, R. Bergthorsdottir, P. Burman, P. Dahlqvist, B. Ekman, B.E. Engstrom, T. Olsson, O. Ragnarsson, M. Ryberg, J. Wahlberg, B.M. Biller, J.P. Monson, P.M. Stewart, H. Lennernas, S. Skrtic, Improved cortisol exposure-time profile and outcome in patients with adrenal insufficiency: a prospective randomized trial of a novel hydrocortisone dual-release formulation. J. Clin. Endocrinol. Metab. 97(2), 473\u2013481 (2012). https:\/\/doi.org\/10.1210\/jc.2011-1926","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"2649_CR36","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","volume":"6","author":"AM Isidori","year":"2018","unstructured":"A.M. Isidori, M.A. Venneri, C. Graziadio, C. Simeoli, D. Fiore, V. Hasenmajer, E. Sbardella, D. Gianfrilli, C. Pozza, P. Pasqualetti, S. Morrone, A. Santoni, F. Naro, A. Colao, R. Pivonello, A. Lenzi, Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial. Lancet Diabetes Endocrinol. 6(3), 173\u2013185 (2018). https:\/\/doi.org\/10.1016\/S2213-8587(17)30398-4","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"5","key":"2649_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1530\/EJE-14-1114","volume":"172","author":"M Quinkler","year":"2015","unstructured":"M. Quinkler, R. Miodini Nilsen, K. Zopf, M. Ventz, M. Oksnes, Modified-release hydrocortisone decreases BMI and HbA1c in patients with primary and secondary adrenal insufficiency. Eur. J. Endocrinol. 172(5), 619\u2013626 (2015). https:\/\/doi.org\/10.1530\/EJE-14-1114","journal-title":"Eur. J. Endocrinol."},{"issue":"6","key":"2649_CR38","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1210\/js.2019-00046","volume":"3","author":"PM Stewart","year":"2019","unstructured":"P.M. Stewart, Modified-Release Hydrocortisone: Is It Time to Change Clinical Practice? J. Endocr. Soc. 3(6), 1150\u20131153 (2019). https:\/\/doi.org\/10.1210\/js.2019-00046","journal-title":"J. Endocr. Soc."},{"issue":"9","key":"2649_CR39","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1185\/03007995.2014.925865","volume":"30","author":"G Johannsson","year":"2014","unstructured":"G. Johannsson, S. Skrtic, H. Lennernas, M. Quinkler, P.M. Stewart, Improving outcomes in patients with adrenal insufficiency: a review of current and future treatments. Curr. Med Res Opin. 30(9), 1833\u20131847 (2014). https:\/\/doi.org\/10.1185\/03007995.2014.925865","journal-title":"Curr. Med Res Opin."},{"issue":"4","key":"2649_CR40","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/cen.12316","volume":"80","author":"M Whitaker","year":"2014","unstructured":"M. Whitaker, M. Debono, H. Huatan, D. Merke, W. Arlt, R.J. Ross, An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clin. Endocrinol. (Oxf.) 80(4), 554\u2013561 (2014). https:\/\/doi.org\/10.1111\/cen.12316","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"13","key":"2649_CR41","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1056\/NEJMra1909786","volume":"383","author":"DP Merke","year":"2020","unstructured":"D.P. Merke, R.J. Auchus, Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. N. Engl. J. Med 383(13), 1248\u20131261 (2020). https:\/\/doi.org\/10.1056\/NEJMra1909786","journal-title":"N. Engl. J. Med"},{"key":"2649_CR42","doi-asserted-by":"publisher","unstructured":"D. Merke, A. Mallappa, W. Arlt, A. Brac de la Perriere, A.L. Hirschberg, A. Juul, J. Newell-Price, C.G. Perry, A. Prete, A. Rees, N. Reisch, M. Stikkelbroeck, P. Touraine, K. Maltby, P. Treasure, J. Porter, R.J. Ross, A phase 3 study of a modified-release hydrocortisone in the treamtment of congenital adrenal hyperplasia. J. Endocrine Soc. 4 (2020). https:\/\/doi.org\/10.1210\/jendso\/bvaa046","DOI":"10.1210\/jendso\/bvaa046"},{"issue":"4","key":"2649_CR43","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1111\/cen.13813","volume":"89","author":"A Mallappa","year":"2018","unstructured":"A. Mallappa, A.A. Nella, N. Sinaii, H. Rao, V. Gounden, A.F. Perritt, P. Kumar, A. Ling, C.Y. Liu, S.J. Soldin, D.P. Merke, Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia. Clin. Endocrinol. (Oxf.) 89(4), 399\u2013407 (2018). https:\/\/doi.org\/10.1111\/cen.13813","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"5","key":"2649_CR44","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1210\/jc.2013-4253","volume":"99","author":"M Oksnes","year":"2014","unstructured":"M. Oksnes, S. Bjornsdottir, M. Isaksson, P. Methlie, S. Carlsen, R.M. Nilsen, J.E. Broman, K. Triebner, O. Kampe, A.L. Hulting, S. Bensing, E.S. Husebye, K. Lovas, Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of addison\u2019s disease: a randomized clinical trial. J. Clin. Endocrinol. Metab. 99(5), 1665\u20131674 (2014). https:\/\/doi.org\/10.1210\/jc.2013-4253","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"11","key":"2649_CR45","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1210\/jc.2014-2433","volume":"99","author":"L Gagliardi","year":"2014","unstructured":"L. Gagliardi, M.A. Nenke, T.R. Thynne, J. von der Borch, W.A. Rankin, D.E. Henley, J. Sorbello, W.J. Inder, D.J. Torpy, Continuous subcutaneous hydrocortisone infusion therapy in Addison\u2019s disease: a randomized, placebo-controlled clinical trial. J. Clin. Endocrinol. Metab. 99(11), 4149\u20134157 (2014). https:\/\/doi.org\/10.1210\/jc.2014-2433","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"2649_CR46","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1530\/EJE-17-0248","volume":"177","author":"U Neumann","year":"2017","unstructured":"U. Neumann, D. Burau, S. Spielmann, M.J. Whitaker, R.J. Ross, C. Kloft, O. Blankenstein, Quality of compounded hydrocortisone capsules used in the treatment of children. Eur. J. Endocrinol. 177(2), 239\u2013242 (2017). https:\/\/doi.org\/10.1530\/EJE-17-0248","journal-title":"Eur. J. Endocrinol."},{"key":"2649_CR47","doi-asserted-by":"publisher","unstructured":"U. Neumann, K. Braune, M.J. Whitaker, S. Wiegand, H. Krude, J. Porter, D. Digweed., B. Voet, R.J.M. Ross, O. Blankenstein, A prospective study of children 0-7 years with cah and adrenal insufficiency treated with hydrocortisone granules. J. Clin. Endocrinol. Metab. (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa626","DOI":"10.1210\/clinem\/dgaa626"},{"issue":"3","key":"2649_CR48","doi-asserted-by":"publisher","first-page":"R115","DOI":"10.1530\/EJE-14-0824","volume":"172","author":"B Allolio","year":"2015","unstructured":"B. Allolio, Extensive expertise in endocrinology. Adrenal Crisis Eur. J. Endocrinol. 172(3), R115\u2013124 (2015). https:\/\/doi.org\/10.1530\/EJE-14-0824","journal-title":"Adrenal Crisis Eur. J. Endocrinol."},{"issue":"9","key":"2649_CR49","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1056\/NEJMra1807486","volume":"381","author":"RL Rushworth","year":"2019","unstructured":"R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crisis. N. Engl. J. Med. 381(9), 852\u2013861 (2019). https:\/\/doi.org\/10.1056\/NEJMra1807486","journal-title":"N. Engl. J. Med."},{"issue":"7","key":"2649_CR50","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/S2213-8587(20)30122-4","volume":"8","author":"RL Rushworth","year":"2020","unstructured":"R.L. Rushworth, D.J. Torpy, H. Falhammar, Adrenal crises in older patients. Lancet Diabetes Endocrinol. 8(7), 628\u2013639 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30122-4","journal-title":"Lancet Diabetes Endocrinol."},{"key":"2649_CR51","doi-asserted-by":"publisher","unstructured":"S.R. Ali, J. Bryce, H. Haghpanahan, J.D. Lewsey, L.E. Tan, N. Atapattu, N.H. Birkebaek, O. Blankenstein, U. Neumann, A. Balsamo, R. Ortolano, W. Bonfig, H.L. Claahsen-van der Grinten, M. Cools, E.C. Costa, F. Darendeliler, S. Poyrazoglu, H. Elsedfy, M.J.J. Finken, C.E. Fluck, E. Gevers, M. Korbonits, G. Guaragna-Filho, T. Guran, A. Guven, S.E. Hannema, C. Higham, I.A. Hughes, R. Tadokoro-Cuccaro, A. Thankamony, V. Iotova, N.P. Krone, R. Krone, C. Lichiardopol, A. Luczay, B.B. Mendonca, T. Bachega, M.C. Miranda, T. Milenkovic, K. Mohnike, A. Nordenstrom, S. Einaudi, H. van der Kamp, A. Vieites, L. de Vries, R.J.M. Ross, S.F. Ahmed, Real world estimates of adrenal insufficiency related adverse events in children with congenital adrenal hyperplasia. J. Clin. Endocrinol. Metab. (2020). https:\/\/doi.org\/10.1210\/clinem\/dgaa694","DOI":"10.1210\/clinem\/dgaa694"},{"issue":"1","key":"2649_CR52","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1530\/EJE-20-0361","volume":"183","author":"W Arlt","year":"2020","unstructured":"W. Arlt, S.E. Baldeweg, S.H.S. Pearce, H.L. Simpson, Endocrinology in the time of covid-19: management of adrenal insufficiency. Eur. J. Endocrinol. 183(1), G25\u2013G32 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0361","journal-title":"Eur. J. Endocrinol."},{"key":"2649_CR53","doi-asserted-by":"publisher","unstructured":"A.M. Isidori, G. Arnaldi, M. Boscaro, A. Falorni, C. Giordano, R. Giordano, R. Pivonello, R. Pofi, V. Hasenmajer, M.A. Venneri, E. Sbardella, C. Simeoli, C. Scaroni, A. Lenzi, COVID-19 infection and glucocorticoids: update from the Italian Society of Endocrinology Expert Opinion on steroid replacement in adrenal insufficiency. J Endocrinol Invest (2020). https:\/\/doi.org\/10.1007\/s40618-020-01266-w","DOI":"10.1007\/s40618-020-01266-w"},{"issue":"6","key":"2649_CR54","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/S2213-8587(20)30149-2","volume":"8","author":"AM Isidori","year":"2020","unstructured":"A.M. Isidori, R. Pofi, V. Hasenmajer, A. Lenzi, R. Pivonello, Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection. Lancet Diabetes Endocrinol. 8(6), 472\u2013473 (2020). https:\/\/doi.org\/10.1016\/S2213-8587(20)30149-2","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"2","key":"2649_CR55","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/EJE-20-0181","volume":"183","author":"S Burger-Stritt","year":"2020","unstructured":"S. Burger-Stritt, A. Eff, M. Quinkler, T. Kienitz, B. Stamm, H.S. Willenberg, G. Meyer, J. Klein, N. Reisch, M. Droste, S. Hahner, Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluation. Eur. J. Endocrinol. 183(2), 119\u2013127 (2020). https:\/\/doi.org\/10.1530\/EJE-20-0181","journal-title":"Eur. J. Endocrinol."},{"issue":"1","key":"2649_CR56","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/cen.13608","volume":"89","author":"S Burger-Stritt","year":"2018","unstructured":"S. Burger-Stritt, P. Kardonski, A. Pulzer, G. Meyer, M. Quinkler, S. Hahner, Management of adrenal emergencies in educated patients with adrenal insufficiency-A prospective study. Clin. Endocrinol. (Oxf.) 89(1), 22\u201329 (2018). https:\/\/doi.org\/10.1111\/cen.13608","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"1","key":"2649_CR57","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ejim.2014.11.006","volume":"26","author":"M Quinkler","year":"2015","unstructured":"M. Quinkler, P. Dahlqvist, E.S. Husebye, O. Kampe, A European Emergency Card for adrenal insufficiency can save lives. Eur. J. Intern Med 26(1), 75\u201376 (2015). https:\/\/doi.org\/10.1016\/j.ejim.2014.11.006","journal-title":"Eur. J. Intern Med"},{"issue":"2","key":"2649_CR58","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1530\/EJE-12-1057","volume":"169","author":"S Hahner","year":"2013","unstructured":"S. Hahner, S. Burger-Stritt, B. Allolio, Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency. Eur. J. Endocrinol. 169(2), 147\u2013154 (2013). https:\/\/doi.org\/10.1530\/EJE-12-1057","journal-title":"Eur. J. Endocrinol."},{"issue":"2","key":"2649_CR59","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/jc.2014-3191","volume":"100","author":"S Hahner","year":"2015","unstructured":"S. Hahner, C. Spinnler, M. Fassnacht, S. Burger-Stritt, K. Lang, D. Milovanovic, F. Beuschlein, H.S. Willenberg, M. Quinkler, B. Allolio, High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J. Clin. Endocrinol. Metab. 100(2), 407\u2013416 (2015). https:\/\/doi.org\/10.1210\/jc.2014-3191","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"2649_CR60","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1530\/EC-16-0054","volume":"5","author":"W Arlt","year":"2016","unstructured":"W. Arlt; Society for Endocrinology Clinical, C., Society for endocrinology endocrine emergency guidance: emergency management of acute adrenal insufficiency (adrenal crisis) in adult patients. Endocr. Connect 5(5), G1\u2013G3 (2016). https:\/\/doi.org\/10.1530\/EC-16-0054","journal-title":"Endocr. Connect"},{"issue":"4","key":"2649_CR61","doi-asserted-by":"publisher","first-page":"337","DOI":"10.2223\/jped.244","volume":"77","author":"PS Esperon","year":"2001","unstructured":"P.S. Esperon, [Hyponatremic coma as a manifestation of Addisons disease]. J. Pediatr. (Rio J.) 77(4), 337\u2013342 (2001). https:\/\/doi.org\/10.2223\/jped.244","journal-title":"J. Pediatr. (Rio J.)"},{"issue":"4","key":"2649_CR62","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/j.1365-2265.2007.03061.x","volume":"68","author":"M Sherlock","year":"2008","unstructured":"M. Sherlock, N.J. Gittoes, W. Arlt, Adrenal crisis causing critical illness related reversible myocardial dysfunction. Clin. Endocrinol. (Oxf.) 68(4), 667\u2013669 (2008). https:\/\/doi.org\/10.1111\/j.1365-2265.2007.03061.x","journal-title":"Clin. Endocrinol. (Oxf.)"},{"issue":"3","key":"2649_CR63","first-page":"377","volume":"16","author":"A Afzal","year":"2000","unstructured":"A. Afzal, F. Khaja, Reversible cardiomyopathy associated with Addison\u2019s disease. Can. J. Cardiol. 16(3), 377\u2013379 (2000)","journal-title":"Can. J. Cardiol."},{"issue":"2","key":"2649_CR64","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/nrendo.2010.211","volume":"7","author":"B Allolio","year":"2011","unstructured":"B. Allolio, K. Lang, S. Hahner, Addisonian crisis in a young man with atypical anorexia nervosa. Nat. Rev. Endocrinol. 7(2), 115\u2013121 (2011). https:\/\/doi.org\/10.1038\/nrendo.2010.211","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"2649_CR65","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1530\/EJE-12-0161","volume":"167","author":"N Reisch","year":"2012","unstructured":"N. Reisch, M. Willige, D. Kohn, H.P. Schwarz, B. Allolio, M. Reincke, M. Quinkler, S. Hahner, F. Beuschlein, Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency. Eur. J. Endocrinol. 167(1), 35\u201342 (2012). https:\/\/doi.org\/10.1530\/EJE-12-0161","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"2649_CR66","doi-asserted-by":"publisher","first-page":"520","DOI":"10.7861\/clinmedicine.13-5-520","volume":"13","author":"HM Elasha","year":"2013","unstructured":"H.M. Elasha, F. Anjum, M.H. Almalki, A young man with a dizzy spell and acute abdominal pain. Clin. Med (Lond.) 13(5), 520\u2013521 (2013). https:\/\/doi.org\/10.7861\/clinmedicine.13-5-520","journal-title":"Clin. Med (Lond.)"},{"issue":"3","key":"2649_CR67","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1530\/EJE-09-0884","volume":"162","author":"S Hahner","year":"2010","unstructured":"S. Hahner, M. Loeffler, B. Bleicken, C. Drechsler, D. Milovanovic, M. Fassnacht, M. Ventz, M. Quinkler, B. Allolio, Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies. Eur. J. Endocrinol. 162(3), 597\u2013602 (2010). https:\/\/doi.org\/10.1530\/EJE-09-0884","journal-title":"Eur. J. Endocrinol."},{"key":"2649_CR68","doi-asserted-by":"publisher","unstructured":"T. Woodcock, P. Barker, S. Daniel, S. Fletcher, J.A.H. Wass, J.W. Tomlinson, U. Misra, M. Dattani, W. Arlt, A. Vercueil, Guidelines for the management of glucocorticoids during the peri-operative period for patients with adrenal insufficiency: Guidelines from the Association of Anaesthetists, the Royal College of Physicians and the Society for Endocrinology UK. Anaesthesia (2020). https:\/\/doi.org\/10.1111\/anae.14963","DOI":"10.1111\/anae.14963"},{"issue":"6","key":"2649_CR69","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.ando.2017.10.008","volume":"78","author":"C Cortet","year":"2017","unstructured":"C. Cortet, P. Barat, D. Zenaty, L. Guignat, P. Chanson, Group 5: Acute adrenal insufficiency in adults and pediatric patients. Ann. Endocrinol. (Paris) 78(6), 535\u2013543 (2017). https:\/\/doi.org\/10.1016\/j.ando.2017.10.008","journal-title":"Ann. Endocrinol. (Paris)"},{"issue":"1","key":"2649_CR70","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1136\/jim-2019-000999","volume":"68","author":"BS Miller","year":"2020","unstructured":"B.S. Miller, S.P. Spencer, M.E. Geffner, E. Gourgari, A. Lahoti, M.K. Kamboj, T.L. Stanley, N.K. Uli, B.A. Wicklow, K. Sarafoglou, Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings. J. Investig. Med. 68(1), 16\u201325 (2020). https:\/\/doi.org\/10.1136\/jim-2019-000999","journal-title":"J. Investig. Med."},{"issue":"1","key":"2649_CR71","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/00006454-198901000-00005","volume":"8","author":"DA Nickels","year":"1989","unstructured":"D.A. Nickels, D.C. Moore, Serum cortisol responses in febrile children. Pediatr. Infect. Dis. J. 8(1), 16\u201320 (1989). https:\/\/doi.org\/10.1097\/00006454-198901000-00005","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"3","key":"2649_CR72","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.beem.2015.04.002","volume":"29","author":"EA Webb","year":"2015","unstructured":"E.A. Webb, N. Krone, Current and novel approaches to children and young people with congenital adrenal hyperplasia and adrenal insufficiency. Best. Pr. Res Clin. Endocrinol. Metab. 29(3), 449\u2013468 (2015). https:\/\/doi.org\/10.1016\/j.beem.2015.04.002","journal-title":"Best. Pr. Res Clin. Endocrinol. Metab."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-021-02649-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-021-02649-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T06:46:31Z","timestamp":1617259591000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-021-02649-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":72,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["2649"],"URL":"https:\/\/doi.org\/10.1007\/s12020-021-02649-6","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"1 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"N.R. is PI of the Chronocort\u00ae Phase III and extension study and of the EU-AIR SHP617-400-P40012 study. The other authors report no conflicts of interest in this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}